Hangzhou Biotest Biotech Co.,Ltd. (688767.SS) — Stock Score Summary

Hangzhou Biotest Biotech Co.,Ltd. (688767.SS) has a MoatMap StockRank of 33/100 based on Quality (56/100), Value (23/100), and Momentum (40/100) factor scores. The current signal is SELL. Hangzhou Biotest Biotech produces point-of-care diagnostic tests. It faces intense post-pandemic competition and pricing pressure, with no clear structural moat or alignment with our high-conviction macro themes.

Hangzhou Biotest Biotech Co., Ltd. develops and manufactures rapid diagnostic test kits (Point-of-Care Testing) covering infectious diseases, drugs of abuse, and oncology. The company has built a highly resilient competitive moat through its extensive portfolio of international regulatory approvals, including US FDA clearances and CE marks, enabling sales in over 100 countries. It is a prominent export-oriented player in the global POCT market.

Key Financial Metrics

Price$5.61
Market Cap$842M
P/E (TTM)177.38
Price/Book2.30
Return on Equity1.2%
Return on Invested Capital1.5%
Debt/Equity0.02
Gross Margin45.0%
Operating Margin-5.0%
Revenue Growth1.7%
Dividend Yield1.9%
Free Cash Flow$-2M

Hangzhou Biotest Biotech Co.,Ltd. operates in the Biotechnology industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Hangzhou Biotest Biotech Co.,Ltd.’s (688767.SS) StockRank?
MoatMap’s StockRank for Hangzhou Biotest Biotech Co.,Ltd. (688767.SS) is 33/100, with a Sell signal. It is a composite of Quality (56), Value (23), and Momentum (40) factor ranks across MoatMap’s 19,000+ stock universe.
Does Hangzhou Biotest Biotech Co.,Ltd. have an economic moat?
Hangzhou Biotest Biotech Co.,Ltd. (688767.SS) has a Quality factor score of 56/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Hangzhou Biotest Biotech Co.,Ltd. a buy, hold, or sell?
MoatMap’s current signal for Hangzhou Biotest Biotech Co.,Ltd. (688767.SS) is Sell, based on a StockRank of 33/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Hangzhou Biotest Biotech Co.,Ltd. in?
Hangzhou Biotest Biotech Co.,Ltd. (688767.SS) operates in the Healthcare sector, specifically the Biotechnology industry (China).
Browse all ranked stocks688767.SS deep dive reportAI ChampionsHow we score stocksSense-check another stock